JP2025090864A5 - - Google Patents

Info

Publication number
JP2025090864A5
JP2025090864A5 JP2025049135A JP2025049135A JP2025090864A5 JP 2025090864 A5 JP2025090864 A5 JP 2025090864A5 JP 2025049135 A JP2025049135 A JP 2025049135A JP 2025049135 A JP2025049135 A JP 2025049135A JP 2025090864 A5 JP2025090864 A5 JP 2025090864A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
antibacterial
intact
tissue
antibacterial pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2025049135A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025090864A (ja
Filing date
Publication date
Priority claimed from JP2019554855A external-priority patent/JP2020513016A/ja
Application filed filed Critical
Publication of JP2025090864A publication Critical patent/JP2025090864A/ja
Publication of JP2025090864A5 publication Critical patent/JP2025090864A5/ja
Pending legal-status Critical Current

Links

JP2025049135A 2017-04-06 2025-03-24 能力と安全性が増強された組成物および抗菌合成カチオン性ポリペプチド類を局所的に適用する使用 Pending JP2025090864A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762482630P 2017-04-06 2017-04-06
US62/482,630 2017-04-06
JP2019554855A JP2020513016A (ja) 2017-04-06 2018-04-05 能力と安全性が増強された組成物および抗菌合成カチオン性ポリペプチド類を局所的に適用する使用
PCT/US2018/026322 WO2018187617A1 (en) 2017-04-06 2018-04-05 Compositions and uses of locally applied antimicrobials with enhanced performance and safety
JP2023028902A JP7656643B2 (ja) 2017-04-06 2023-02-27 能力と安全性が増強された組成物および抗菌合成カチオン性ポリペプチド類を局所的に適用する使用

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2023028902A Division JP7656643B2 (ja) 2017-04-06 2023-02-27 能力と安全性が増強された組成物および抗菌合成カチオン性ポリペプチド類を局所的に適用する使用

Publications (2)

Publication Number Publication Date
JP2025090864A JP2025090864A (ja) 2025-06-17
JP2025090864A5 true JP2025090864A5 (https=) 2026-01-06

Family

ID=63712780

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2019554855A Pending JP2020513016A (ja) 2017-04-06 2018-04-05 能力と安全性が増強された組成物および抗菌合成カチオン性ポリペプチド類を局所的に適用する使用
JP2023028902A Active JP7656643B2 (ja) 2017-04-06 2023-02-27 能力と安全性が増強された組成物および抗菌合成カチオン性ポリペプチド類を局所的に適用する使用
JP2025049135A Pending JP2025090864A (ja) 2017-04-06 2025-03-24 能力と安全性が増強された組成物および抗菌合成カチオン性ポリペプチド類を局所的に適用する使用

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2019554855A Pending JP2020513016A (ja) 2017-04-06 2018-04-05 能力と安全性が増強された組成物および抗菌合成カチオン性ポリペプチド類を局所的に適用する使用
JP2023028902A Active JP7656643B2 (ja) 2017-04-06 2023-02-27 能力と安全性が増強された組成物および抗菌合成カチオン性ポリペプチド類を局所的に適用する使用

Country Status (11)

Country Link
US (3) US11285189B2 (https=)
EP (1) EP3606543A4 (https=)
JP (3) JP2020513016A (https=)
KR (2) KR20200018400A (https=)
CN (1) CN110740744A (https=)
AU (2) AU2018249552A1 (https=)
BR (1) BR112019020781A2 (https=)
CA (1) CA3058901C (https=)
MX (2) MX393548B (https=)
SG (1) SG11201909016TA (https=)
WO (1) WO2018187617A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2991989T3 (es) 2012-03-23 2024-12-05 Macro Biologics Inc Composiciones y usos de materiales antimicrobianos con propiedades compatibles con tejidos
US11285189B2 (en) 2017-04-06 2022-03-29 Amicrobe, Inc. Compositions and uses of locally-applied antimicrobial synthetic cationic polypeptide(s) with enhanced performance and safety
JP2023501385A (ja) 2019-11-08 2023-01-18 ユニバーシティ オブ ピッツバーグ - オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション 抗微生物ペプチドを含む組成物
WO2021202577A1 (en) * 2020-03-31 2021-10-07 3-D Matrix, Ltd. Sterilization of self-assembling peptides by irradiation
US20230149333A1 (en) * 2020-04-08 2023-05-18 Amicrobe, Inc. Compositions and uses of locally applied synthetic amino acid polymers for prevention and treatment of viral infections
US12371463B2 (en) 2021-04-20 2025-07-29 University of Pittsburgh—of the Commonwealth System of Higher Education Methods and compositions for treatment of antibiotic-resistant bacterial infections

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5636643A (en) 1991-11-14 1997-06-10 Wake Forest University Wound treatment employing reduced pressure
US6686446B2 (en) 1998-03-19 2004-02-03 The Regents Of The University Of California Methods and compositions for controlled polypeptide synthesis
US6632922B1 (en) 1998-03-19 2003-10-14 The Regents Of The University Of California Methods and compositions for controlled polypeptide synthesis
US6680365B1 (en) 1998-03-19 2004-01-20 The Regents Of The University Of California Methods and compositions for controlled polypeptide synthesis
TW570805B (en) 1998-09-01 2004-01-11 Hoffmann La Roche Water-soluble pharmaceutical composition in an ionic complex
US8206749B1 (en) 1999-02-26 2012-06-26 Novartis Vaccines And Diagnostics, Inc. Microemulsions with adsorbed macromolecules and microparticles
MXPA03002640A (es) 2000-09-28 2003-06-19 Chiron Corp Microparticulas para la distribucion de acidos nucleicos heterologos.
US6835536B2 (en) 2001-08-21 2004-12-28 Micrologix Biotech Inc. Antimicrobial cationic peptides and formulations thereof
US6818732B2 (en) 2001-08-30 2004-11-16 The Regents Of The University Of California Transition metal initiators for controlled poly (beta-peptide) synthesis from beta-lactam monomers
JP2003171463A (ja) * 2001-12-06 2003-06-20 Chisso Corp ポリリジン及びその製造法
CA2443472A1 (en) 2002-02-07 2003-08-14 Ophtecs Corporation Liquid formulation for contact lenses
CN103405405A (zh) 2002-12-09 2013-11-27 阿布拉西斯生物科学有限责任公司 组合物和传递药剂的方法
EP1644382B1 (en) 2003-07-11 2008-03-05 Theravance, Inc. Cross-linked glycopeptide-cephalosporin antibiotics
WO2005018701A1 (en) 2003-08-25 2005-03-03 Kane Biotech Inc. Synergistic antimicrobial compositions and methods of inhibiting biofilm formation
WO2005063278A1 (en) 2003-12-30 2005-07-14 Bioactive Polymers Ab Surface protection of exposed biological tissues
ATE381945T1 (de) * 2004-03-12 2008-01-15 Intercell Ag Verfahren zur solubilisierung von peptid- mischungen
PL1778720T3 (pl) 2004-08-18 2011-03-31 Novabiotics Ltd Antybakteryjne peptydy zawierające wzór zawierający argininę i/lub lizynę
EP1891097B1 (en) 2005-06-06 2016-11-16 Adenium Biotech ApS Polypeptides having antimicrobial activity and polynucleotides encoding same
US20080139450A1 (en) 2005-07-01 2008-06-12 Srinivasa Madhyastha Antimicrobial Compositions and Uses Thereof
US20070190110A1 (en) 2006-02-10 2007-08-16 Pameijer Cornelis H Agents and devices for providing blood clotting functions to wounds
CA2671461C (en) 2006-12-01 2014-01-28 The Regents Of The University Of California Vesicles of self-assembling block copolymers and methods for making and using the same
CN101720237A (zh) 2007-06-25 2010-06-02 利波佩普蒂德有限公司 新型医用产品
WO2009032605A2 (en) 2007-08-27 2009-03-12 Massachusetts Institute Of Technology Bi-functional polymer-attached inhibitors of influenza virus
KR20110031168A (ko) 2008-06-19 2011-03-24 니뽄 신야쿠 가부시키가이샤 약물 담체
CN102256613B (zh) 2008-10-20 2014-09-10 莫伊莱麦屈克斯公司 用于治疗或者预防粘连的多肽
WO2010083589A1 (en) 2009-01-23 2010-07-29 Kane Biotech Inc. Biofilm-removing antimicrobial compositions and uses thereof
GB0905451D0 (en) 2009-03-31 2009-05-13 Novabiotics Ltd Biofilms
SG184836A1 (en) 2010-04-27 2012-11-29 Lysando Ag Method of reducing biofilms
SG188281A1 (en) 2010-08-23 2013-04-30 Univ California Compositions and uses of materials with high antimicrobial activity and low toxicity
JP5613779B2 (ja) * 2011-01-19 2014-10-29 株式会社メニコン コンタクトレンズ用液剤
US9781949B2 (en) 2011-03-31 2017-10-10 The University Of Massachusetts Antimicrobial delivery systems, methods of manufacture, and methods of use thereof
ES2991989T3 (es) 2012-03-23 2024-12-05 Macro Biologics Inc Composiciones y usos de materiales antimicrobianos con propiedades compatibles con tejidos
DE102014101663A1 (de) 2014-02-11 2015-08-13 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Synthetische artifizielle Peptide mit antimikrobieller Wirkung
WO2016044683A1 (en) 2014-09-19 2016-03-24 Tensive Controls, Inc. Anti-microbial peptides
EP3215126A1 (en) 2014-10-30 2017-09-13 Biomet Manufacturing, LLC Methods of preventing surgical site infections
JP2016113373A (ja) * 2014-12-11 2016-06-23 エスポ化学株式会社 抗菌性、抗ウイルス性を有する水溶性組成物
US11285189B2 (en) 2017-04-06 2022-03-29 Amicrobe, Inc. Compositions and uses of locally-applied antimicrobial synthetic cationic polypeptide(s) with enhanced performance and safety
US20210007999A1 (en) 2018-03-02 2021-01-14 January Therapeutics, Inc. Nanoparticle compositions

Similar Documents

Publication Publication Date Title
JP2025090864A5 (https=)
CA1199272A (en) Topical antimicrobial composition
ES2805225T3 (es) Péptidos antimicrobianos y composiciones de los mismos
RU2553363C2 (ru) Антисептические композиции и их применения
JP2023054375A5 (https=)
JP5294876B2 (ja) ハイドロゲル
US20060240116A1 (en) Bioactive factors in wound healing topical compositions and methods
KR20140117379A (ko) Dgla, 15-ohepa 및/또는 15-hetre를 포함하는 항미생물 조성물 및 그의 사용 방법
JP2015514782A (ja) 微生物感染症の局所的治療のための組成物
CN101325965B (zh) 治疗粘膜破坏性炎症的转铁蛋白的应用
JP2020513016A5 (https=)
US9480669B2 (en) Method of destroying and preventing bacterial and fungal biofilm by amino acid infusion
CN1140266C (zh) 二醇与α羟基酸的混合物在治疗角化过度性皮肤病中的用途
CN103347507A (zh) 用于治疗痤疮的褪黑激素以及抗微生物剂或抗菌剂
JP2010505942A (ja) 上皮細胞増殖因子を含有する安定な口内炎治療用液状組成物
ITMI990449A1 (it) Cerotto con spessore sottile contenente betametasone ed acido ialuronico per il trattamento di psoriasi dermatite dermatosi
PT1374903E (pt) Composições farmacêuticas para a prevenção do desenvolvimento e progressão de micoses cutâneas superficiais.
CA2489705C (en) Use of amide derivative of ge 2270 factor a3 for the treatment of acne
JP2018530622A (ja) 尿路感染症を治療するための組成物および方法
US20220023244A1 (en) Formulation for topical treatment of acute wounds
RU2512757C1 (ru) Антибактериальное и регенерирующее средство, выполненное в форме маслянистого геля для наружного применения
JPH0782169A (ja) 創傷治療剤
ITMI20091122A1 (it) Formulazioni farmaceutiche per uso intravaginale nella prevenzione e terapia delle vulvo vaginiti e nel ripristino della fisiologia vaginale
CA3077447A1 (en) Method to treat antimicrobial resistant candida
EP4132468A1 (en) Compositions and uses of locally applied synthetic amino acid polymers for prevention and treatment of viral infections